Nasdaq

Cytek® Biosciences Deepens Commitment to Expanding Access to Flow Cytometry

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...
Seeking Alpha

Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer

FREMONT, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- In a move that underscores its dedication to shaping the future of cell analysis, Cytek Biosciences, Inc. (CTKB) (Nasdaq: CTKB) today announced the ...
EurekAlert!

Revolutionizing impedance flow cytometry with adjustable microchannel height

Impedance flow cytometry measurements are adversely affected by the distance between the analyte and the sensing electrodes. By slightly squeezing the microfluidic channel, adapts the channel’s height ...
Nasdaq

Cytek Biosciences Launches Cytek Aurora™ Evo System Enhancing Full Spectrum Flow Cytometry Capabilities

Cytek Biosciences, Inc. has announced the launch of the Cytek Aurora™ Evo system, an advanced full spectrum flow cytometer designed to enhance cell analysis capabilities. Building on the success of ...
KXAN

TD2 Oncology Expands Flow Cytometry Expertise to Advance In Vivo CAR-T Therapies for Autoimmune and Oncology Development

TD2 Oncology delivers fully integrated preclinical, regulatory, and clinical services for cancer drug development. In response to advances in In Vivo CAR-T engineering, TD2 Oncology launches flow ...